Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medical decision support system using weakly-labeled lung CT scans.
Murillo-González A, González D, Jaramillo L, Galeano C, Tavera F, Mejía M, Hernández A, Rivera DR, Paniagua JG, Ariza-Jiménez L, Garcés Echeverri JJ, Diaz León CA, Serna-Higuita DL, Barrios W, Arrázola W, Mejía MÁ, Arango S, Marín Ramírez D, Salinas-Miranda E, Quintero OL. Murillo-González A, et al. Among authors: galeano c. Front Med Technol. 2022 Sep 28;4:980735. doi: 10.3389/fmedt.2022.980735. eCollection 2022. Front Med Technol. 2022. PMID: 36248019 Free PMC article.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: galeano c. Br J Cancer. 2024 May;130(8):1414. doi: 10.1038/s41416-024-02667-x. Br J Cancer. 2024. PMID: 38575733 Free PMC article. No abstract available.
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Rio-Vilariño A, Cenigaonandia-Campillo A, García-Bautista A, Mateos-Gómez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, García-García L, Galeano C, de Miguel I, Serrano-López J, Baños N, Fernández-Aceñero MJ, Lacal JC, Medico E, García-Foncillas J, Cebrián A. Rio-Vilariño A, et al. Among authors: galeano c. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. Br J Cancer. 2024. PMID: 38467828 Free PMC article.
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry.
López-Oliva MO, Pérez-Flores I, Molina M, José Aladrén M, Trujillo H, Redondo-Pachón D, López V, Facundo C, Villanego F, Rodríguez M, Carmen Ruiz M, Antón P, Rivas-Oural A, Cabello S, Portolés J, de la Vara L, Tabernero G, Valero R, Galeano C, Moral E, Ventura A, Coca A, Ángel Muñoz M, Hernández-Gallego R, Shabaka A, Ledesma G, Bouarich H, Ángeles Rodríguez M, Pérez Tamajón L, Cruzado L, Emilio Sánchez J, Jiménez C. López-Oliva MO, et al. Among authors: galeano c. Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):442-451. doi: 10.1016/j.nefroe.2023.08.004. Epub 2023 Sep 1. Nefrologia (Engl Ed). 2023. PMID: 37661514 Free article.
Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry.
Franco A, Moreso F, Solà-Porta E, Beneyto I, Esforzado N, Gonzalez-Roncero F, Sancho A, Melilli E, Ruiz JC, Galeano C; Renal Transplantation with HCV Positive Donors Spanish Study Group. Franco A, et al. Among authors: galeano c. J Clin Med. 2023 Feb 23;12(5):1773. doi: 10.3390/jcm12051773. J Clin Med. 2023. PMID: 36902560 Free PMC article.
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Corral JM, Puerto-Nevado LD, Cedeño M, Río-Vilariño A, Mahillo-Fernández I, Galeano C, Baños N, García-Foncillas J, Dómine M, Cebrián A. Corral JM, et al. Among authors: galeano c. Biomed Pharmacother. 2022 Dec;156:113987. doi: 10.1016/j.biopha.2022.113987. Epub 2022 Nov 8. Biomed Pharmacother. 2022. PMID: 36411654 Free article.
[Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry.].
López-Oliva MO, Pérez-Flores I, Molina M, José Aladrén M, Trujillo H, Redondo-Pachón D, López V, Facundo C, Villanego F, Rodríguez M, Carmen Ruiz M, Antón P, Rivas-Oural A, Cabello S, Portolés J, de la Vara L, Tabernero G, Valero R, Galeano C, Moral E, Ventura A, Coca A, Muñoz MÁ, Hernández-Gallego R, Shabaka A, Ledesma G, Martínez P, Ángeles Rodríguez M, Tamajón LP, Cruzado L, Emilio Sánchez J, Jiménez C. López-Oliva MO, et al. Among authors: galeano c. Nefrologia. 2022 Apr 30. doi: 10.1016/j.nefro.2022.03.008. Online ahead of print. Nefrologia. 2022. PMID: 35528867 Free PMC article. Spanish.
Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
Caravaca-Fontán F, Polanco N, Villacorta B, Buxeda A, Coca A, Ávila A, Martínez-Gallardo R, Galeano C, Valero R, Ramos N, Allende N, Cruzado-Vega L, Pérez-Sáez MJ, Sevillano Á, González E, Hernández A, Rodrigo E, Fernández-Ruiz M, Aguado JM, Pérez Valdivia MÁ, Pascuall J, Andrés A, Praga M; Spanish Group for the Study of Glomerular Diseases and the Spanish Group of Kidney Transplant. Caravaca-Fontán F, et al. Among authors: galeano c. Nephrol Dial Transplant. 2023 Jan 23;38(1):222-235. doi: 10.1093/ndt/gfac148. Nephrol Dial Transplant. 2023. PMID: 35404425
130 results